Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · Real-Time Price · USD

1.550

-0.020 (-1.27%)

At close: Jul 13, 2026, 4:00 PM EDT

1.570

+0.020 (1.29%)

After-hours: Jul 13, 2026, 5:26 PM EDT

Outlook Therapeutics Employees

Outlook Therapeutics had 17 employees as of September 30, 2025. The number of employees decreased by 6 or -26.09% compared to the previous year.

Employees

Change (1Y)

-6

Growth (1Y)

-26.09%

Revenue / Employee

$19,597

Profits / Employee

-$3,585,676

Market Cap

187.34M

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Sep 30, 2025	17	-6	-26.09%
Sep 30, 2024	23	-1	-4.17%
Sep 30, 2023	24	7	41.18%
Sep 30, 2022	17	8	88.89%
Sep 30, 2021	9	1	12.50%
Sep 30, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
Protalix BioTherapeutics	226
Humacyte	184
MediWound	121
Arcturus Therapeutics Holdings	111
Caribou Biosciences	97
Alpha Cognition	71
Tenaya Therapeutics	70
Acumen Pharmaceuticals	61